drugset
Drugs / Clade B gag DNA/PLG and env DNA/PLG Microparticles
last change Apr 2011 re-read 3 minutes ago

Clade B gag DNA/PLG and env DNA/PLG Microparticles

Vaccine

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT00073216 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00073216 ? → Sep 2007 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Clade B gag DNA/PLG and env DNA/PLG Microparticles ClinicalTrials.gov intervention name — accepted as the source's own label NCT00073216 ↗
Modality Vaccine “Clade B Gag DNA/PLG and Env DNA/PLG Microparticles Vaccine” NCT00073216 ↗
Route Intramuscular “Priming was performed via intramuscular injection with gag and env DNA adsorbed to polylactide coglycolide microspheres” PMID 21451004 ↗ Apr 2011